Altamira Therapeutics Ltd (CYTO) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Altamira Therapeutics Ltd   (NASDAQ: CYTO)

Altamira Therapeutics Ltd Profitability Comparisons

Select each Category to receive further Information




CYTO Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q4 MRQ) - 66.53 % 56.46 % 32.42 %
Gross Margin (Q4 TTM) - 63.81 % 52.84 % 35.69 %
Gross Profit Margin 5 Yr. Avg. - 59.14 % 51.06 % 32.17 %
EBITDA Margin (Q4 MRQ) - 21.87 % 20.8 % 25.58 %
EBITDA Margin (Q4 TTM) - 23.59 % 19.1 % 21.45 %
EBITDA Margin 5 Yr. Avg. - 33.6 % 26.97 % 22.17 %
Operating Margin (Q4 MRQ) - 11.67 % 11.52 % 21.93 %
Operating Margin (Q4 TTM) - 13.56 % 11.68 % -11.74 %
Operating Margin 5 Yr. Avg. - 15.97 % 15.1 % 15.82 %
Pre-Tax Profit Margin (Q4 MRQ) - 10.82 % 8.67 % 10.66 %
Pre-Tax Profit Margin (Q4 TTM) - 10.4 % 7.33 % 11.61 %
Pre-Tax Profit Margin 5 Yr. Avg. - 14.1 % 11.56 % 11.23 %
Net Margin (Q4 MRQ) - 12.91 % 9.7 % 9.22 %
Net Margin (Q4 TTM) - 12.39 % 7.89 % 9.47 %
Net Margin 5 Yr. Avg. - 8.04 % 7.57 % 8.81 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q4 MRQ) - 0.83 % 1.01 % 0.64 %
Free Cash Flow Margin (Q4 TTM) - 16.61 % 12.35 % 11.14 %
Free Cash Flow Margin 5 Yr. Avg. - 23.82 % 18.01 % 16.22 %
Net Cash Flow Margin (Q4 MRQ) - 4.93 % 2.18 % 0.21 %
Net Cash Flow Margin (Q4 TTM) - 4.92 % 4.44 % 10.32 %
Net Cash Flow Margin 5 Yr. Avg. - 7.05 % 4.88 % 29.58 %
Effective Tax Rate (Q4 MRQ) - - 5.19 % 10.57 %
Effective Tax Rate (Q4 TTM)